Quarter
Charts

Atara Biotherapeutics, Inc.

ATRA

CIK 0001604464 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$2M
↓-95.1% -$31Mvs FY2024 (Q4)
Operating Income
$703K
↓-71.2% -$2Mvs FY2024 (Q4)
Gross Profit
$2M
↓-95.1% -$31Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
36/100
  • Profitability
    0ROIC -52.8% (10% = solid, 20%+ = moat)
  • Liquidity
    16Current Ratio 0.82 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    100Asset Turnover 1.87x (1.0+ = capital-efficient)
  • Growth
    0Revenue YoY -95.1% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -103.5% · trend +62.1pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$0
investment in PP&E
Stock-based comp (TTM)
$10M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$20M
everything owned
Total liabilities
$59M
everything owed
Stockholders' equity
$-39M
shareholder claim

Recent performance · 51 quarters

Revenue↓-95.1% -$31M
$2M
Net Income↑+80.4% +$18M
$-4M
Free Cash Flow↑+100.0% +$90K
$0
Operating Margin↓-49.4pts
-103.5%

Drill down

ATRA Sankey

See Atara Biotherapeutics, Inc.'s revenue flow into every line item of the income statement and balance sheet — every dollar accounted for, with prior-period comparison.

Open Sankey

ATRA Charts

51 quarters of historical line items — Income, Cash Flow, Balance Sheet, plus margins. Click any chart for the trend dialog.

Open Charts

ATRA Key Metrics

EPS, BVPS, FCF/Share, ROE, ROA, ROIC, D/E, Current Ratio, Quick Ratio, Asset Turnover — 10 CFA-grade fundamentals derived from EDGAR data.

Open Key Metrics